Bharat Parenterals Ltd has announced that it will purchase an additional 9,985,477 equity shares of its subsidiary, Innoxel Lifesciences Pvt Ltd, on a preferential basis. Each share has a face value of ₹10 and will be acquired at a premium of ₹54.90, making the total price per share ₹64.90. The target entity is Innoxel Lifesciences …